Clinical Trials
3 trialsNCT03216343 2023-08-30
Phase Ib/II Study of Chiauranib in Patients With Small Cell Lung Cancer
Chipscreen Biosciences, Ltd.
Phase 1 Completed
NCT03074825 2019-07-24
Study of Chiauranib in Relapsed/Refractory Non-Hodgkin's Lymphoma
Chipscreen Biosciences, Ltd.
Phase 1 Terminated
NCT02122809 2016-06-17
Phase I Study of Chiauranib in Patients With Advanced Solid Tumors
Chipscreen Biosciences, Ltd.
Phase 1 Completed